Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the personalized cell therapy market grown in recent years?

The personalized cell therapy market has expanded exponentially, growing from $17.11 billion in 2024 to $21 billion in 2025, with a CAGR of 22.8%. Past growth was driven by increasing awareness of personalized medicine, higher healthcare spending, government initiatives, increased funding for clinical research, and a rise in neurological disorders.

How is the personalized cell therapy market size expected to evolve during the forecast period?

The personalized cell therapy market is set for exponential growth, reaching $47.14 billion by 2029 at a CAGR of 22.4%. Growth is driven by the rise in clinical trials, increasing chronic illness cases, a growing aging population, higher cancer prevalence, and the expanding use of regenerative medicine. Key trends include AI-driven innovations, bioinformatics advancements, personalized vaccines, and microfluidic technology integration.

Get your personalized cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report

Which key drivers are propelling the personalized cell therapy market’s growth?

The rise in neurological disorders is anticipated to propel the personalized cell therapy market. Neurological disorders affect the brain, spinal cord, and nerves, leading to symptoms like cognitive deficits and motor impairment. These conditions are increasing due to aging populations and environmental factors. Personalized cell therapy offers tailored treatments to address specific patient needs, potentially restoring damaged neural tissue. For instance, in December 2022, the Parkinson Foundation reported that the annual incidence of Parkinson’s disease among older individuals was 50% higher than previously estimated. Therefore, the rise in neurological disorders is boosting the personalized cell therapy market.

What are the market segments in the personalized cell therapy industry?

The personalized cell therapymarket covered in this report is segmented –

1) By Cell Type: Lymphocytes, Mesenchymal Stem Cell, Hematopoietic Stem Cell, Other Cell Type

2) By Technique: Platelet Transfusions, Bone Marrow Transplantation, Packed Red Cell Transfusions, Organ Transplantation

3) By Application: Cardiovascular Diseases, Neurological Disorders, Inflammatory Diseases, Diabetes, Cancer, Other Applications

4) By End-User: Hospital, Homecare, Specialty Clinics, Other End-User

Subsegments:

1) By Lymphocytes: T Cells, Natural Killer (NK) Cells, Regulatory T Cells

2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs, Adipose Tissue-Derived MSCs, Umbilical Cord-Derived MSCs

3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells, Allogeneic Hematopoietic Stem Cells

4) By Other Cell Types: Dendritic Cells, Fibroblasts, Endothelial Cells

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp

Which leading companies are shaping the growth of the personalized cell therapy market?

Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

What key trends are currently impacting the personalized cell therapy market’s development?

Prominent corporations in the personalized cell therapy market are concentrating on establishing strategic alliances to expedite the progression and introduction of novel therapies. These partnerships allow businesses to combine their resources, skills, and technologies to improve research and development competencies, streamline clinical tests, and effectively handle regulatory pathways. For example, Century Therapeutics Inc., an American biotech firm, allied with Bristol Myers Squibb (BMS), a US biopharmaceutical corporation, in October 2022, to foster and bring to market allogeneic cell therapies. The partnership leverages Century’s groundbreaking induced pluripotent stem cell (iPSC) methodology to fabricate engineered natural killer (NK) and T cell therapies to address hematologic malignancies and solid tumors. The pact includes the cultivation of up to four separate cell therapy initiatives, primarily concentrating on two particular domains: acute myeloid leukemia (AML) and multiple myeloma. These initiatives will employ engineered NK cells or gamma delta T cells sourced from iPSCs.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19137

Which geographic areas are influencing the growth of the personalized cell therapy market?

North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cell Therapy Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Personalized Medicine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: